981 results on '"Nelde A"'
Search Results
2. iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens
3. TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification
4. Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
5. FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
6. Data lake-driven analytics identify nocturnal non-dipping of heart rate as predictor of unfavorable stroke outcome at discharge
7. TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification
8. Quantification of systematic errors in the electron density and temperature measured with Thomson scattering at W7-X
9. Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
10. Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISM
11. Feedback induced locking in semiconductor lasers with strong amplitude-phase coupling
12. 872 Combined multi-omics analysis delineates the impact of epigenetic therapies on the immunopeptidome of acute myeloid leukemia
13. 1463 The intra-tumoral spatial heterogeneity of T cell antigens in glioblastoma: An integrated multi-omics approach
14. Validation of HLA presented tumor-exclusive peptides in an independent cohort of head and neck squamous cell carcinoma.
15. Datawarehouse-enabled quality control of atrial fibrillation detection in the stroke unit setting
16. Datawarehouse-enabled quality control of atrial fibrillation detection in the stroke unit setting
17. Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
18. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
19. Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
20. Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity
21. FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
22. A supervised, externally validated machine learning model for artifact and drainage detection in high-resolution intracranial pressure monitoring data
23. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
24. Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms
25. Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
26. Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity
27. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
28. A supervised, externally validated machine learning model for artifact and drainage detection in high-resolution intracranial pressure monitoring data.
29. FusionVAC22_01: A phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion.
30. Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A*03 and HLA-B*15 via peptide-PRISM
31. Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome
32. Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens
33. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
34. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
35. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
36. When East Met West: Cold War, Elusive Peace and Other Little Things
37. 1463 The intra-tumoral spatial heterogeneity of T cell antigens in glioblastoma: An integrated multi-omics approach
38. Supplementary Figures S1-S13 from Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
39. Data from Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
40. Supplementary Tables S1 to S15 from Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
41. 872 Combined multi-omics analysis delineates the impact of epigenetic therapies on the immunopeptidome of acute myeloid leukemia
42. Machine learning using multimodal and autonomic nervous system parameters predicts clinically apparent stroke-associated pneumonia in a development and testing study
43. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
44. Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms
45. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
46. Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome
47. Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
48. Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
49. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
50. Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.